Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system.

Blumenthal PD, Dawson L, Hurskainen R.

Int J Gynaecol Obstet. 2011 Mar;112(3):171-8. doi: 10.1016/j.ijgo.2010.08.025. Epub 2011 Jan 26. Review.

PMID:
21269626
2.

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Lethaby A, Hussain M, Rishworth JR, Rees MC.

Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. Review.

PMID:
25924648
3.

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Lethaby AE, Cooke I, Rees M.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD002126.

PMID:
16235297
4.

Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Health Quality Ontario .

Ont Health Technol Assess Ser. 2016 Nov 1;16(18):1-119. eCollection 2016. Review.

5.

The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.

Ganz ML, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J, Law A.

Value Health. 2013 Mar-Apr;16(2):325-33. doi: 10.1016/j.jval.2012.11.011.

6.

Surgery versus medical therapy for heavy menstrual bleeding.

Marjoribanks J, Lethaby A, Farquhar C.

Cochrane Database Syst Rev. 2016 Jan 29;(1):CD003855. doi: 10.1002/14651858.CD003855.pub3. Review.

PMID:
26820670
7.

Cost-effectiveness of treatments for heavy menstrual bleeding.

Spencer JC, Louie M, Moulder JK, Ellis V, Schiff LD, Toubia T, Siedhoff MT, Wheeler SB.

Am J Obstet Gynecol. 2017 Nov;217(5):574.e1-574.e9. doi: 10.1016/j.ajog.2017.07.024. Epub 2017 Jul 25.

PMID:
28754438
8.

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.

Gupta JK, Daniels JP, Middleton LJ, Pattison HM, Prileszky G, Roberts TE, Sanghera S, Barton P, Gray R, Kai J; ECLIPSE Collaborative Group.

Health Technol Assess. 2015 Oct;19(88):i-xxv, 1-118. doi: 10.3310/hta19880.

9.

Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.

Bahamondes MV, de Lima Y, Teich V, Bahamondes L, Monteiro I.

Contraception. 2012 Sep;86(3):244-50. doi: 10.1016/j.contraception.2011.12.005. Epub 2012 Mar 28.

PMID:
22459236
10.

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Dominick S, Hickey M, Chin J, Su HI.

Cochrane Database Syst Rev. 2015 Dec 9;(12):CD007245. doi: 10.1002/14651858.CD007245.pub3. Review.

PMID:
26649916
11.

The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.

Shaw V, Vandal AC, Coomarasamy C, Ekeroma AJ.

Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):619-623. doi: 10.1111/ajo.12528. Epub 2016 Oct 3.

PMID:
27696346
12.
13.

The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.

Kaunitz AM, Inki P.

Drugs. 2012 Jan 22;72(2):193-215. doi: 10.2165/11598960-000000000-00000. Review.

PMID:
22268392
14.

Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.

Cihangir U, Ebru A, Murat E, Levent Y.

Int J Gynaecol Obstet. 2013 Nov;123(2):146-9. doi: 10.1016/j.ijgo.2013.05.018. Epub 2013 Jul 31.

PMID:
24028852
15.

Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.

Calaf J, Lete I, Canals I, Crespo C, Espinós B, Cristóbal I.

Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:24-31. doi: 10.1016/j.ejogrb.2014.10.034. Epub 2014 Oct 30.

PMID:
25462215
16.

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Chin J, Konje JC, Hickey M.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007245. doi: 10.1002/14651858.CD007245.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007245.

PMID:
19821400
17.

Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.

Brown PM, Farquhar CM, Lethaby A, Sadler LC, Johnson NP.

BJOG. 2006 Jul;113(7):797-803.

18.

Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.

Roberts TE, Tsourapas A, Middleton LJ, Champaneria R, Daniels JP, Cooper KG, Bhattacharya S, Barton PM.

BMJ. 2011 Apr 26;342:d2202. doi: 10.1136/bmj.d2202. Review.

19.

Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain.

Lete I, Cristóbal I, Febrer L, Crespo C, Arbat A, Hernández FJ, Brosa M.

Eur J Obstet Gynecol Reprod Biol. 2011 Jan;154(1):71-80. doi: 10.1016/j.ejogrb.2010.08.019. Epub 2010 Oct 15.

PMID:
20951492
20.

Surgery versus medical therapy for heavy menstrual bleeding.

Marjoribanks J, Lethaby A, Farquhar C.

Cochrane Database Syst Rev. 2003;(2):CD003855. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003855.

PMID:
12804492

Supplemental Content

Support Center